Estatinas, drogas de amplio espectro de acción y beneficios / Statins, drugs with a wide spectrum of action and benefits
Rev. Hosp. Clin. Univ. Chile
;
30(3): 238-251, 2019. graf, tab
Article
in Spanish
| LILACS
| ID: biblio-1051224
ABSTRACT
Prevention and treatment of dyslipidemia should therefore be considered as an integral part of individual cardiovascular prevention interventions, which should be addressed primarily to those at higher risk who will benefit most. Statins are the most commonly used options for the pharmacologic treatment of dyslipidemia. In recent decades, numerous clinical trials have demonstrated the efficacy of these drugs to reduce cardiovascular mortality and major non-fatal atherothrombotic events in heterogeneous populations through both primary and secondary prevention. This group of drugs is part of the recommendations of both US and European guidelines, and should be prescribed to all patients who have already had a cardiovascular event and have no specific contraindication. However, a large percentage of patients that would benefit from a statin treatment do not receive them, have been prescribed a low dose or for a limited time. (AU)
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Type of study:
Practice guideline
Limits:
Humans
Language:
Spanish
Journal:
Rev. Hosp. Clin. Univ. Chile
Journal subject:
Medicine
Year:
2019
Type:
Article
Affiliation country:
Venezuela
Institution/Affiliation country:
Fundación Venezolana de Cardiología Preventiva/VE
Similar
MEDLINE
...
LILACS
LIS